Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...
Major depressive disorder (MDD), perhaps the most common form of depression (APA, 2013), has many subtypes, each with its unique characteristics and treatment needs. I was recently reviewing this with ...
The US FDA has approved lumateperone (Caplyta, Johnson & Johnson) for use as adjunctive therapy with antidepressants for the treatment of adults with major depressive disorder (MDD). The approval of ...
A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally different way of treating depression symptoms in adults with major ...
A major depressive episode can evolve from seemingly minor "blues" with surprising speed, eventually disrupting your career, ...
Everyday Health on MSN
Why 'better' isn't enough: Bridging the remission gap in depression treatment
You can still have significant symptoms even if your depression treatment is working. Learn about strategies including ...
Please provide your email address to receive an email when new articles are posted on . Brain-derived neurotrophic factor levels are low among patients with major depressive disorder but high among ...
In a recent study published in JAMA Network Open, researchers explored how structural and functional aspects of the brain, as seen through neuroimaging, differ between individuals with high exposure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results